In the field of tick vaccines, most success has been recorded with slow-feeding species, which have prolonged contact with the host immune system. There are grounds to think that better tick vaccines could be developed fairly easily. The potential for increased efficacy, by using more than one recombinant antigen in a formulation, has been demonstrated experimentally, while the number of antigens available for trial is steadily increasing (68).